Does NADROPARIN Cause Interstitial lung disease? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Interstitial lung disease have been filed in association with NADROPARIN. This represents 2.2% of all adverse event reports for NADROPARIN.
15
Reports of Interstitial lung disease with NADROPARIN
2.2%
of all NADROPARIN reports
2
Deaths
15
Hospitalizations
How Dangerous Is Interstitial lung disease From NADROPARIN?
Of the 15 reports, 2 (13.3%) resulted in death, 15 (100.0%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NADROPARIN. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does NADROPARIN Cause?
Foetal exposure during pregnancy (81)
Off label use (77)
Premature baby (73)
Maternal exposure during pregnancy (72)
Drug ineffective (54)
Sepsis (46)
Dyspnoea (44)
Fall (43)
Exposure during pregnancy (42)
Confusional state (40)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which NADROPARIN Alternatives Have Lower Interstitial lung disease Risk?
NADROPARIN vs NAFARELIN
NADROPARIN vs NAFCILLIN
NADROPARIN vs NAFCILLIN\NAFCILLIN
NADROPARIN vs NAFRONYL
NADROPARIN vs NAFTIFINE